Pregnancy With Insomnia: a Trial of Acupuncture (GAS)
Primary Purpose
Insomnia
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Acupuncture needles
Sponsored by
About this trial
This is an interventional treatment trial for Insomnia focused on measuring Insomnia, Pregnancy, Acupuncture, Insomnia severity index, Pittsburgh Sleep Quality Index, Anxiety, Depression
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years
- Singleton pregnancy
- Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
- Insomnia Severity Index ≥ 10
- Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
- Patient understanding the study
- Informed consent signed
- Social insurance available at inclusion and until the end of pregnancy
Exclusion Criteria:
- Threatened premature labor
- Small fetus for gestational age
- Pre-eclampsia
- Insomnia starting before pregnancy
- Use of psychotropic drugs before pregnancy
- Use of recreational drugs during pregnancy
- Known psychiatric disorder
- Anticoagulant therapy
- Patient reporting insomnia results from chronic or acute pain
- Obstructive sleep apnea (OSA) requiring treatment
- Patient under antidepressant therapy
- Patient under legal guardianship or deprived of freedom
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Regular acupuncture needles
Sham acupuncture needles
Arm Description
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
Outcomes
Primary Outcome Measures
Insomnia severity index (ISI)
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Secondary Outcome Measures
Pittsburgh Sleep Quality Index (PSQI)
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Hospital Anxiety and Depression Scale (HADS)
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of each psychotropic medicine
During the study period, the patients will note on a logbook the daily use of any drug.
Cumulated dose of alcohol
During the study period, the patients will note on a logbook the daily use of alcohol.
Cumulated dose of tobacco
During the study period, the patients will note on a logbook the daily use of tobacco.
Cumulated dose of cannabis
During the study period, the patients will note on a logbook the daily use of cannabis.
Cumulated dose of other recreational substances or medicine
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Difference in the frequency of restless leg syndrome
According to the guidelines of the International Restless Legs Syndrome Study Group.
The diagnosis of restless leg will rely on the presence of all of the following criteria:
Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
Symptoms are worse at rest with at least temporary relief by activity.
Symptoms are worse later in the day or at night.
Perinatal outcome - Gestational age at birth
The gestational age at birth of the newborn will be recorded.
Perinatal outcome - birth weight
The weight (in gr) at birth of the newborn will be recorded.
Perinatal outcome - birth height
The height (in cm) at birth of the newborn will be recorded.
Perinatal outcome - sex
The sex of the newborn will be recorded.
Perinatal outcome - perinatal mortality
The perinatal mortality will be recorded.
Perinatal outcome - five minutes Apgar score
The five minutes Apgar score will be recorded.
Perinatal outcome - cesarean section rate
Cesarean section rate will be recorded.
Full Information
NCT ID
NCT03194191
First Posted
May 23, 2017
Last Updated
June 27, 2017
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT03194191
Brief Title
Pregnancy With Insomnia: a Trial of Acupuncture
Acronym
GAS
Official Title
Pregnancy With Insomnia: a Trial of Acupuncture
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Unknown status
Study Start Date
September 2017 (Anticipated)
Primary Completion Date
January 2019 (Anticipated)
Study Completion Date
May 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.
GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.
Detailed Description
Scientific justification:
- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.
Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.
To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.
Population:
The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.
Objectives:
Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .
Study design:
Study Type: Multicentre, Interventional, randomized, 2 parallel groups
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single blind (patient blinded to intervention)
Primary Purpose: Treatment
One acupuncture session weekly for 4 consecutive weeks
Visits:
Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia
Keywords
Insomnia, Pregnancy, Acupuncture, Insomnia severity index, Pittsburgh Sleep Quality Index, Anxiety, Depression
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial with regular acupuncture needles vs. sham needles. In addition, the sham needles will be placed in areas that do not correspond to any known acupuncture point.
5 bilateral acupoints or placebo acupoints,
Masking
Participant
Masking Description
Single blind (patient blinded to intervention)
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Regular acupuncture needles
Arm Type
Experimental
Arm Description
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
Arm Title
Sham acupuncture needles
Arm Type
Sham Comparator
Arm Description
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
Intervention Type
Device
Intervention Name(s)
Acupuncture needles
Intervention Description
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Primary Outcome Measure Information:
Title
Insomnia severity index (ISI)
Description
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Secondary Outcome Measure Information:
Title
Pittsburgh Sleep Quality Index (PSQI)
Description
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Hospital Anxiety and Depression Scale (HADS)
Description
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Cumulated dose of each psychotropic medicine
Description
During the study period, the patients will note on a logbook the daily use of any drug.
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Cumulated dose of alcohol
Description
During the study period, the patients will note on a logbook the daily use of alcohol.
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Cumulated dose of tobacco
Description
During the study period, the patients will note on a logbook the daily use of tobacco.
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Cumulated dose of cannabis
Description
During the study period, the patients will note on a logbook the daily use of cannabis.
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Cumulated dose of other recreational substances or medicine
Description
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Difference in the frequency of restless leg syndrome
Description
According to the guidelines of the International Restless Legs Syndrome Study Group.
The diagnosis of restless leg will rely on the presence of all of the following criteria:
Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
Symptoms are worse at rest with at least temporary relief by activity.
Symptoms are worse later in the day or at night.
Time Frame
Inclusion visit and 5 weeks after the first acupuncture session
Title
Perinatal outcome - Gestational age at birth
Description
The gestational age at birth of the newborn will be recorded.
Time Frame
At birth
Title
Perinatal outcome - birth weight
Description
The weight (in gr) at birth of the newborn will be recorded.
Time Frame
At birth
Title
Perinatal outcome - birth height
Description
The height (in cm) at birth of the newborn will be recorded.
Time Frame
At birth
Title
Perinatal outcome - sex
Description
The sex of the newborn will be recorded.
Time Frame
At birth
Title
Perinatal outcome - perinatal mortality
Description
The perinatal mortality will be recorded.
Time Frame
At birth
Title
Perinatal outcome - five minutes Apgar score
Description
The five minutes Apgar score will be recorded.
Time Frame
At birth
Title
Perinatal outcome - cesarean section rate
Description
Cesarean section rate will be recorded.
Time Frame
At birth.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 18 years
Singleton pregnancy
Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
Insomnia Severity Index ≥ 10
Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
Patient understanding the study
Informed consent signed
Social insurance available at inclusion and until the end of pregnancy
Exclusion Criteria:
Threatened premature labor
Small fetus for gestational age
Pre-eclampsia
Insomnia starting before pregnancy
Use of psychotropic drugs before pregnancy
Use of recreational drugs during pregnancy
Known psychiatric disorder
Anticoagulant therapy
Patient reporting insomnia results from chronic or acute pain
Obstructive sleep apnea (OSA) requiring treatment
Patient under antidepressant therapy
Patient under legal guardianship or deprived of freedom
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Stéphanie Nicolian, Midewife
Phone
0033 6 25 71 08 64
Email
snicolian@yahoo.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Marc Dommergues, PUPH
Phone
0033 6 08 48 69 25
Email
marc.dommergues@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stéphanie Nicolian, Midewife
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Pregnancy With Insomnia: a Trial of Acupuncture
We'll reach out to this number within 24 hrs